DK0814790T3 - Indgivelse af ketamin med henblik på afgiftning - Google Patents
Indgivelse af ketamin med henblik på afgiftningInfo
- Publication number
- DK0814790T3 DK0814790T3 DK96906452T DK96906452T DK0814790T3 DK 0814790 T3 DK0814790 T3 DK 0814790T3 DK 96906452 T DK96906452 T DK 96906452T DK 96906452 T DK96906452 T DK 96906452T DK 0814790 T3 DK0814790 T3 DK 0814790T3
- Authority
- DK
- Denmark
- Prior art keywords
- ketamine
- administration
- present
- substance addiction
- treatment
- Prior art date
Links
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 title abstract 6
- 229960003299 ketamine Drugs 0.000 title abstract 6
- 238000001784 detoxification Methods 0.000 title abstract 3
- 208000011117 substance-related disease Diseases 0.000 abstract 4
- 235000019504 cigarettes Nutrition 0.000 abstract 1
- 235000019788 craving Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000007922 nasal spray Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1995/002418 WO1995022965A2 (en) | 1994-02-25 | 1995-02-24 | Nasal and ocular administration of ketamine to manage pain and for detoxification |
| US08/477,365 US5679714A (en) | 1995-06-07 | 1995-06-07 | Administration of ketamine for detoxification and treatment of tobacco addiction |
| PCT/US1996/002047 WO1996025925A1 (en) | 1995-02-24 | 1996-02-14 | Nasal and ocular administration of ketamine to manage pain and for detoxification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0814790T3 true DK0814790T3 (da) | 2003-11-10 |
Family
ID=26789531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96906452T DK0814790T3 (da) | 1995-02-24 | 1996-02-14 | Indgivelse af ketamin med henblik på afgiftning |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0814790B1 (da) |
| JP (1) | JP4173538B2 (da) |
| AT (1) | ATE245024T1 (da) |
| AU (1) | AU733284B2 (da) |
| CA (1) | CA2213567C (da) |
| DE (1) | DE69629108T2 (da) |
| DK (1) | DK0814790T3 (da) |
| ES (1) | ES2205018T3 (da) |
| WO (1) | WO1996025925A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140274981A1 (en) | 2013-03-15 | 2014-09-18 | Janssen Pharmaceutica Nv | Pharmaceutical composition of s-ketamine hydrochloride |
| AU2015318123A1 (en) | 2014-09-15 | 2017-03-30 | Janssen Pharmaceutica Nv | Val66Met (SNP rs6265) genotype specific dosing regimens and methods for the treatment of depression |
| US10555952B2 (en) | 2015-06-19 | 2020-02-11 | Melt Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for anesthesiological applications |
| US10166240B2 (en) | 2015-06-19 | 2019-01-01 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for anesthesiological applications |
| US10391102B2 (en) | 2015-06-19 | 2019-08-27 | Melt Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for anesthesiological applications |
| US10179136B2 (en) | 2015-06-19 | 2019-01-15 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for anesthesiological applications |
| US9918993B2 (en) * | 2015-06-19 | 2018-03-20 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for anesthesiological applications |
| US20200297734A1 (en) | 2015-06-19 | 2020-09-24 | Melt Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for anesthesiological applications |
| US20200009081A1 (en) | 2017-09-13 | 2020-01-09 | Janssen Pharmaceutica N.V. | Delivery Of Esketamine For The Treatment Of Depression |
| KR20240011237A (ko) | 2017-12-22 | 2024-01-25 | 얀센 파마슈티카 엔브이 | 우울증 치료를 위한 에스케타민 |
| ES2907692T3 (es) | 2017-12-29 | 2022-04-26 | Celon Pharma Sa | Composición de ketamina de polvo seco para su administración por vía pulmonar en la depresión resistente al tratamiento |
| JP2022524008A (ja) | 2019-03-05 | 2022-04-27 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | うつ病の治療のためのエスケタミン |
| JP7847233B2 (ja) * | 2022-04-26 | 2026-04-16 | イーチャン・ヒューマンウェル・ファーマシューティカル・カンパニー・リミテッド | エスケタミン液体製剤及びその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5288498A (en) * | 1985-05-01 | 1994-02-22 | University Of Utah Research Foundation | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
| US5543434A (en) * | 1994-02-25 | 1996-08-06 | Weg; Stuart L. | Nasal administration of ketamine to manage pain |
-
1996
- 1996-02-14 DK DK96906452T patent/DK0814790T3/da active
- 1996-02-14 EP EP96906452A patent/EP0814790B1/en not_active Expired - Lifetime
- 1996-02-14 AT AT96906452T patent/ATE245024T1/de active
- 1996-02-14 DE DE69629108T patent/DE69629108T2/de not_active Expired - Lifetime
- 1996-02-14 CA CA2213567A patent/CA2213567C/en not_active Expired - Fee Related
- 1996-02-14 ES ES96906452T patent/ES2205018T3/es not_active Expired - Lifetime
- 1996-02-14 JP JP52574596A patent/JP4173538B2/ja not_active Expired - Fee Related
- 1996-02-14 AU AU49827/96A patent/AU733284B2/en not_active Ceased
- 1996-02-14 WO PCT/US1996/002047 patent/WO1996025925A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP4173538B2 (ja) | 2008-10-29 |
| WO1996025925A1 (en) | 1996-08-29 |
| AU4982796A (en) | 1996-09-11 |
| CA2213567A1 (en) | 1996-08-29 |
| DE69629108T2 (de) | 2004-04-22 |
| AU733284B2 (en) | 2001-05-10 |
| DE69629108D1 (de) | 2003-08-21 |
| ATE245024T1 (de) | 2003-08-15 |
| ES2205018T3 (es) | 2004-05-01 |
| EP0814790B1 (en) | 2003-07-16 |
| EP0814790A1 (en) | 1998-01-07 |
| CA2213567C (en) | 2010-01-26 |
| JPH11500729A (ja) | 1999-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0814790T3 (da) | Indgivelse af ketamin med henblik på afgiftning | |
| MX9603633A (es) | Administracion nasal y ocular de ketamina para manejar el dolor y para la detoxificacion. | |
| CA2146954A1 (en) | Breath activated nicotine inhalers | |
| ATE276676T1 (de) | Zusammensetzung zur reduzierung oder entwöhnung von nikotinabhängigkeit | |
| CA1152003A (en) | Means and method for aiding individuals to stop smoking | |
| DK0863760T3 (da) | Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning | |
| WO2001080837A3 (de) | Transdermale oder transmucosale darreichungsformen mit einer nicotinhaltigen wirkstoffkombination zur raucherentwöhnung | |
| BRPI0412931A (pt) | tratamento da supressão de dependência | |
| RO116771B1 (ro) | Metodă pentru prevenirea sau tratamentul dependenţei, toleranţei sau abuzului de benzodiazepine | |
| UA27884C2 (uk) | Засіб для лікування розладів, викликаних зловживанням ліками та спосіб лікування або профілактики зазначеним засобом абстинентного синдрому | |
| EA004184B1 (ru) | Способ уменьшения или прекращения курения | |
| ATE301462T1 (de) | Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden | |
| US6224897B1 (en) | Methods to abate the use of tobacco by humans | |
| MX9706456A (es) | Administracion nasal y ocular de la cetamina para manejar el dolor y para la destoxificacion. | |
| NO943293L (no) | Anvendelse av et medikament ved avvenning mot röyk | |
| DE69733321D1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
| Richmond et al. | Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy: 6-Months’ Results | |
| JP2004505053A (ja) | 喫煙の減少または解消方法 | |
| SU1537259A1 (ru) | Средство, подавл ющее влечение к никотину и табачному дыму | |
| Antonuccio | Will the nicotine patch really stick? | |
| MY142346A (en) | Medicament and method for reducing alcohol and/or tobacco consumption | |
| PROTOCOL | Western Regional Emergency Medical Advisory Committee | |
| UA42352A (uk) | Спосіб лікування хронічного гастродуоденіту із супутніми захворюваннями внутрішніх органів |